The quality of research with real-world evidence
Article Sidebar
Main Article Content
Most of the medical practice has not been proven by controlled clinical trials, and there are no plans to conduct such trials in order to decrease clinician uncertainty. This happens partly due to the difficulty of making designs with scientific and ethical validity, the costs of this type of research and the time required to generate results, which can be several years. Clinical trials do not have the capability to generate information that allows to make decisions in some sectors of clinical care and public health, such as when an epidemic occurs. Therefore, medical science is based on observational studies, past practices and therapeutic tradition (1).
Observation of clinical data that have defined a clinical behavior precedes the clinical trial. The knowledge about scurvy, the fact that this pathology is considered a nutritional deficiency and its treatment with citrus fruits, originated thanks to the collection of clinical data on sailors, soldiers and prisoners of the British Crown in the 18th and 19th centuries (2). This clinical information, which was collected uniformly and served to produce new knowledge, is what is now known as Real World Data (RWD). A modern definition of RWD would be one that talks about data obtained by any non-interventionist methodology that is collected prospectively and retrospectively from observations of routine clinical practice, and which comes from various sources including data from patients, doctors, hospitals, payers, social data, etc (3).
- The quality of research
- Editorial Policies
- Data Collections
- Peer Review / standards
- Data collection
- Epidemiologic Methods
- Medical Records Systems, Computerized
- Reproducibility of Results
- Ethical Analysis
- Real World Data
- Real World Evidence
- RECORD Statement
- Reporting guidelines to pharmacoepidemiological research
- RECORD_PE
- REporting of studies Conducted using Observational Routinely-collected Data
Mauricio Palacios Gómez, Universidad del Valle. Cali, Colombia
MD from the Universidad Nacional de Colombia, Master in Pharmacology and PhD in Biomedical Sciences from the Universidad del Valle. Professor at the Universidad del Valle and director of the Centro de Estudios Cerebrales. He is a researcher in the area of experimental pharmacology and pharmacoepidemiology.
He has been a part of Colombia Médica journal editorial committe since 2008 and He is currently the editor of the journal since 2015. As editor, he has implemented the use of bibliometric technology resources and editorial standards that improve the international visibility of the journal.
https://orcid.org/0000-0001-8091-9954Downloads
- Mauricio Palacios Gómez, The uncertainty of colombian scientific journals with Publindex , Colombia Medica: Vol. 48 No. 4 (2017)
- Mauricio Palacios Gómez, Yiny Torres Valencia, The need for education about death in medical practice , Colombia Medica: Vol. 53 No. 4 (2022): The death debate
- Mauricio Palacios Gómez, Editorial progress of the Colombia Médica journal , Colombia Medica: Vol. 50 No. 4 (2019)
- Mauricio Palacios Gómez, Human intelligence for authors, reviewers and editors using artificial intelligence , Colombia Medica: Vol. 54 No. 3 (2023)
- Mauricio Palacios Gómez, How to organize science and technology information in Latin America? , Colombia Medica: Vol. 47 No. 3 (2016)
- Mauricio Palacios Gómez, From trial and error to Equator Network , Colombia Medica: Vol. 43 No. 3 (2012)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use